Skip Navigation

COVID-19 Update

Due to interest in the COVID-19 vaccines, we are experiencing an extremely high call volume. Please understand that our phone lines must be clear for urgent medical care needs. We are unable to accept phone calls to schedule COVID-19 vaccinations at this time. When this changes, we will update this website. Our vaccine supply remains limited. Read all COVID-19 Vaccine Information.

Patient Care Options | Visitor Guidelines | Coronavirus Information | Self-Checker | Get Email Alerts

Brett Andrew McCray, M.D., Ph.D.

Headshot of Brett Andrew McCray
  • Assistant Professor of Neurology


Charcot Marie Tooth Disease (CMT)


Dr. Brett McCray is an assistant professor in neurology whose research interest is furthering understanding of the molecular pathogenesis of Charcot-Marie-Tooth disease and other inherited forms of axonal neuropathy. The goals of his research are to identify common pathways that are disrupted across various forms of Charcot-Marie-Tooth disease and to identify therapeutic targets that can ultimately lead to the development of treatments. His current studies focus on how mutations in the cation channel TRPV4 and the mitochondrial protein mitofusin2 (MFN2) lead to axonal forms of Charcot-Marie-Tooth disease. Dr. McCray's research uses a combined strategy of analyzing cultured cells, primary neurons, mouse models, and Drosophila models to elucidate pathways important in the pathogenesis of neuropathy. His earlier studies explored the axonal trafficking protein Rab7 lead to a subtype of Charcot-Marie-Tooth disease. more


  • Assistant Professor of Neurology

Departments / Divisions

Centers & Institutes



  • MD; University of Pennsylvania School of Medicine (2011)


  • Neurology; Brigham and Women's Hospital (2015)


  • Neuromuscular Medicine; Johns Hopkins University School of Medicine (2016)

Patient Ratings & Comments

The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

  • ...Loading ratings...
  • ... 
  • ... 
  • ... 
  • ... 
  • ... 


Is this you? Edit Profile
back to top button